| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $158.2M | +20.6% |
| R&D Expense | $148.1M | -34.9% |
| SG&A Expense | $120.6M | +4.4% |
| Operating Income | -$127.8M | +41.2% |
| Income Tax | -$2.0M | -127.7% |
| Net Income | -$107.3M | -12.4% |
| EPS (Basic) | -$1.04 | -2.0% |
| EPS (Diluted) | -$1.04 | -2.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $197.1M | +57.7% |
| Short-term Investments | $244.0M | -40.0% |
| Accounts Receivable | $26.7M | +92.7% |
| Inventory | $6.3M | +90.5% |
| Current Assets | $485.1M | -13.7% |
| Total Assets | $507.8M | -12.9% |
| Current Liabilities | $60.5M | -17.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$103.8M | -32.8% |
| Capital Expenditures | $320K | -85.2% |
| Investing Cash Flow | $174.6M | +175.6% |
| Financing Cash Flow | $1.2M | -99.4% |
| Free Cash Flow | -$104.1M | -29.6% |
| Total Liabilities |
| $66.7M |
| -16.7% |
| Stockholders' Equity | $441.2M | -12.3% |